Rudradip Das

Palaj, GJ 382355, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

2,5-Diazabicyclo[2.2.1]heptane in medicinal chemistry: a treasure trove of therapeutic opportunities.

2,5-Diazabicyclo[2.2.1]heptane in medicinal chemistry: a treasure trove of therapeutic opportunities.

Journal: RSC medicinal chemistry
Published: November 05, 2025

Recent progress in the development of small molecule pyruvate kinase M2 inhibitors: 2020-2025.

Recent progress in the development of small molecule pyruvate kinase M2 inhibitors: 2020-2025.

Journal: Future medicinal chemistry
Published: October 24, 2025

IMID-284: a potent pyruvate kinase M2 inhibitor with dual anti-inflammatory and analgesic effects in intervertebral disc disease.

IMID-284: a potent pyruvate kinase M2 inhibitor with dual anti-inflammatory and analgesic effects in intervertebral disc disease.

Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
Published: May 07, 2025

Imidazopyrimidine-based pyruvate kinase M2 activator halts diabetic nephropathy progression via modulating epithelial-to-mesenchymal transition and fibrosis.

Imidazopyrimidine-based pyruvate kinase M2 activator halts diabetic nephropathy progression via modulating epithelial-to-mesenchymal transition and fibrosis.

Journal: Chemico-biological interactions
Published: March 10, 2025

Carbohydrate kinase inhibition: a promising strategy in cancer treatment.

Carbohydrate kinase inhibition: a promising strategy in cancer treatment.

Journal: Drug discovery today
Published: December 09, 2024

Synthesis, characterization, and microbiological evaluation of new triazolopyrimidine-based ferrocenes as potent antimicrobial prospects.

Synthesis, characterization, and microbiological evaluation of new triazolopyrimidine-based ferrocenes as potent antimicrobial prospects.

Journal: Journal of inorganic biochemistry
Published: November 25, 2024

Modulation of the LIMK Pathway by Myricetin: A Protective Strategy Against Neurological Impairments in Spinal Cord Injury.

Modulation of the LIMK Pathway by Myricetin: A Protective Strategy Against Neurological Impairments in Spinal Cord Injury.

Journal: Neurospine
Published: May 28, 2024

Novel sulfonamides unveiled as potent anti-lung cancer agents via tumor pyruvate kinase M2 activation.

Novel sulfonamides unveiled as potent anti-lung cancer agents via tumor pyruvate kinase M2 activation.

Journal: RSC medicinal chemistry
Published: May 19, 2024

Mechanistic Investigation of Thiazole-Based Pyruvate Kinase M2 Inhibitor Causing Tumor Regression in Triple-Negative Breast Cancer.

Mechanistic Investigation of Thiazole-Based Pyruvate Kinase M2 Inhibitor Causing Tumor Regression in Triple-Negative Breast Cancer.

Journal: Journal of medicinal chemistry
Published: February 26, 2024

Targeted suppression of oral squamous cell carcinoma by pyrimidine-tethered quinoxaline derivatives.

Targeted suppression of oral squamous cell carcinoma by pyrimidine-tethered quinoxaline derivatives.

Journal: RSC medicinal chemistry
Published: January 18, 2024

Comprehensive characterization and preclinical assessment of an imidazopyridine-based anticancer lead molecule.

Comprehensive characterization and preclinical assessment of an imidazopyridine-based anticancer lead molecule.

Journal: Drug development research
Published: October 03, 2023

Roadmap to Pyruvate Kinase M2 Modulation - A Computational Chronicle.

Roadmap to Pyruvate Kinase M2 Modulation - A Computational Chronicle.

Journal: Current drug targets
Published: October 01, 2022
Showing 1-12 of 21

Last Updated: 09/26/2026